Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
GSK and Abbott Announce Leadership Changes in Key Roles
Company

GSK and Abbott Announce Leadership Changes in Key Roles

February 19, 2025
Medtronic Q3 Earnings Show 4.1% Organic Growth, Driven by Cardiac Ablation
Company

Medtronic Q3 Earnings Show 4.1% Organic Growth, Driven by Cardiac Ablation

February 19, 2025
QuantumPharm and Hengjian Launch GBA AI+ Innovation Consortium
CompanyDeals

QuantumPharm and Hengjian Launch GBA AI+ Innovation Consortium

February 19, 2025
Deepwise Information Integrates DeepSeek into Medical Data Platform
Company

Deepwise Information Integrates DeepSeek into Medical Data Platform

February 19, 2025
Weimai Qingtong Medical Technology Completes Tens of Millions Yuan B+ Round
Company

Weimai Qingtong Medical Technology Completes Tens of Millions Yuan B+ Round

February 19, 2025
InnoCare Pharma Receives NMPA Approval for Mesutoclax Phase III Study in CLL/SLL
CompanyDrug

InnoCare Pharma Receives NMPA Approval for Mesutoclax Phase III Study in CLL/SLL

February 18, 2025
Hengrui Pharma's HR19034 Eye Drops for Myopia Delay Accepted by NMPA
CompanyDrug

Hengrui Pharma’s HR19034 Eye Drops for Myopia Delay Accepted by NMPA

February 18, 2025
Gan & Lee Pharmaceuticals Doses First Patient in GZR4 Phase III Study for Diabetes
CompanyDrug

Gan & Lee Pharmaceuticals Doses First Patient in GZR4 Phase III Study for Diabetes

February 18, 2025
Stedical Scientific Raises RMB100M in Series B Financing for Global Expansion
CompanyDeals

Stedical Scientific Raises RMB100M in Series B Financing for Global Expansion

February 18, 2025
Zelgen Biopharmaceuticals' ZG005 Bispecific Antibody Receives NMPA Approval for Biliary Tract Cancer Trials
CompanyDrug

Zelgen Biopharmaceuticals’ ZG005 Bispecific Antibody Receives NMPA Approval for Biliary Tract Cancer Trials

February 18, 2025
Bristol-Myers Squibb Releases Five-Year Data on Sotyktu's Long-Term Efficacy and Safety
CompanyDrug

Bristol-Myers Squibb Releases Five-Year Data on Sotyktu’s Long-Term Efficacy and Safety

February 18, 2025
Wanbangde New Building Materials' Mecobalamin Earns FDA Orphan Drug Designation for ALS
CompanyDrug

Wanbangde New Building Materials’ Mecobalamin Earns FDA Orphan Drug Designation for ALS

February 18, 2025
1 2 … 246 247 248 249 250 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up